Tripos combines information technology and scientific research to optimize and accelerate its customers' molecular research for new drug discovery. Its customers include the majority of the world's pharmaceutical companies. And the collaboration was driven by the customers' demand for grid-ready life science applications.

"This collaboration is a major step forward for the life sciences community," said Amith Viswanath, industry manager, Healthcare and Life Sciences IT at Frost and Sullivan. "More and more companies are recognizing that end user applications must become merged with a grid middleware backbone to drive the next generation of research. The main end result of such convergence is a significant increase in research scope, greater data access capabilities across the enterprise and a reduction in overall workflow costs."

"... we have spent the past two decades staying ahead of the technology curve to better serve our customers," said Edward Hodgkin, Tripos vice president of marketing and business development. "This alliance with United Devices is another way in which we are meeting industry needs."

"It is exciting to couple the proven scientific benefits of Tripos' software with the speed and scope of research attainable on a grid platform," said Paul Kirchoff, United Devices' vice president of marketing and business development. "Both companies are eager to respond to this growing customer need."